Absolute Markets Insights added recently released new research report on Plant-Based Biologics Market 2022 by Top Manufacturers, Regions, Type and Application, Forecast provides updates and information related to industry coverage, current market competitive status, and market outlook. Plant-Based Biologics market report is a particular investigation of the business which clarifies what the market definition, arrangements, applications, commitment, and worldwide industry patterns are. This market research report serves to be an exceptionally huge segment of business system. Excellent practice models and method of research utilized while generating this industry report reveals the best opportunities to thrive in the market. With the market data of this report, emerging trends along with major drivers, challenges and opportunities in the market for Plant-Based Biologics industry can be identified and analysed. Plant-Based Biologics market report presents market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, their preferences for particular product and market demand and supply scenarios.
For More Information Click Here : https://www.absolutemarketsinsights.com/reports/Plant-Based-Biologics-2020-2028-791
Global plant-based biologics market is anticipated to grow at a CAGR of 26.45% over the forecast period. Some of the players operating in the plant-based biologics market are Byondis, eleva GmbH, Eversea Inc, iBio, Inc, Icon Genetics GmbH, InVitria, Kentucky BioProcessing, Inc., Leaf Expression Systems, Mapp Biopharmaceutical, Inc., Medicago Inc., OnePointOne, Inc., Pfizer Inc., Planet Biotechnology Inc., PlantForm, Protalix Biotherapeutics, Ventria Bioscience Inc., Zea Biosciences, amongst others.
Diseases have been affecting human civilizations since time immemorial. The global disease burden cost billions of dollars in revenue. Companies around the globe, both private and public, are increasingly trying to reduce the impact of diseases on human beings by developing both therapeutic and diagnostic biologics. Biologics, also called as biological drugs, is a product which is derived from living organisms, or contains some components of living organisms. Traditionally, animal-based biologics have been used for the treatment of diseases. Gelatin, for instance, is a partially hydrolysed collagen which is derived from bovine or porcine living organisms.
Gelatin forms the basis of numerous capsule shells, and is also being used as a stabilizing agent in pharmaceutical products such as vaccines. However, religious practices and concerns regarding the humane treatment of animals for developing animal-based vaccines are prompting researches to move towards plant-based biologics. Furthermore, plant-based biologics are also economical to produce on a large scale, as compared to animal-based products. Also, these products have been proven to be effective agents in controlling pathogens, making it suitable for use as food additives. Bacterial colicins, for instance, is derived from plants.
Global Plant-Based Biologics Market:
By Clinical Trial
- Phase I
- Phase II
- Others
By Source
- Tobacco, tobacco cells, tobacco leaves
- Nicotiana benthamiana leaves
- Carrot cell culture
- Rice seeds
- Moss
- Algae
- Duckweed Leafy Biomass
- Others
By Product
- Taliglucerase alfa
- ZMApp
- PRX-102
- HAI-05
- Others
By Diseases
- HIV/AIDS
- Ebola virus
- Cholera
- Leprosy
- Tuberculosis
- Fabry Disease
- Anthrax
- Pompe Disease
- Influenza
- Type A
- Type B
- Type c
- Alzheimer
- Respiratory Syndromes
- Gaucher disease
- Cancer
- Others
By Mode of Administration
- Intramuscular
- Oral Administration
- Others
By End Users
- Hospitals
- Clinics
- Primary Care Centers
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Contact Us:
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +91-740-024-2424, US +1-510-420-1213
Contact Name: Shreyas Tanna
Website: www.absolutemarketsinsights.com